Further, Cord Blood has initiated, but has not completed its due diligence. Also, each acquisition would require Cord first to locate and obtain additional capital on commercially reasonable terms in order to consummate the acquisition. No such arrangements are currently in place, it is uncertain whether such additional capital can be obtained. As a result, although management is optimistic, there can be no assurance that any of the contemplated acquisitions will occur, and at this date there is no obligation on the Company’s part to proceed with any of these acquisitions.
So besides the incompleted DD, lack of favorable financing, and no assurance,with one business day left in the month, and taking above into account, some posters would imply from unsubstantiated rumor that a reasonable investor should believe that this will close in October.